[2] [3] However, reduced effectiveness can have multiple causes, and patients should consult their healthcare provider rather than simply replacing the medication
Were talking about 0.5% to 1% volume effect 10 years down the road and that assumes quite significant adoption rates of the drug
We think not
If this signal holds across TRIUMPH-1, TRIUMPH-2, and TRIUMPH-3, retatrutide could end up with a lipid profile that no other compound in the class shares
In an eight-week placebo-controlled study of 60 women with BMIs from 25 to 28, those taking 176.5 mg per day of Satiereala type of saffron extractshowed greater reductions in snacking frequency and body weight compared to the placebo group
Outcomes were retrieved from different real-world databases in VID (primary care electronic records, in-hospital and outpatient hospital records and emergency room records), via ICD codes registered during healthcare encounters (see ESM Table 1)